Abstract
Performance of the new CE-IVD-marked HercepTest (TM) mAb pharmDx (Dako Omnis) assay (HercepTest (mAb)) was compared against the PATHWAY (R) anti-HER-2......
小提示:本篇文献需要登录阅读全文,点击跳转登录